running

Full-time Faculty

Wen-Jen Lin

Field of study:Nanomedicine, Pharmaceutical dosage form design, Pharmacokinetics, Stability.
Telephone:(02)3366-8765
E-mail:wjlin@ntu.edu.tw
My job:Professor
Personal website:https://scholars.lib.ntu.edu.tw/cris/rp/rp06461

Education : Ph.D. in Pharmaceutics, University of Iowa, USA
Experience : Professor
Leader of Pharmaceutical Research Group, Drug Research Center
Honor : Ching-Kang Foundation Young Teacher award
Professor Li Jhao Ren Foundation Research Scholar award
Research Areas : Nanomedicine, Pharmaceutical dosage form design, Pharmacokinetics, Stability.
Lab Focus : Our research interest basically focuses on the area of advanced targeting and delivery systems of polymers. We use the modification and synthesis techniques to develop novel polymers with special character and targeting function. Meanwhile, we apply the concept of dosage form design to develop the nanoparticulate/microparticulate delivery systems. The combination of functional polymers and particulate delivery system to achieve targeting and delivery of drug to specific areas of the body is our perspective. The other research interests include the design of micropore-controlled membranes and tablets, and the development of a novel hot-melt fabrication method for microparticles.
Research Subjects : 1. To establish the passive/active targeted nanoparticle/micelle platform for siRNA, pDNA and anticancer drugs delivery
2. To establish the nanoparticle platform for sustained and stomach-specific oral delivery of acid labile drugs
3. To develop novel functional hyaluronic acid conjugated niosomes for skin anti-aging
4. To establish the micropore controlled delivery system combined with osmotic driven mechanism to sustain and control drug release

Improve BBB Penetration and Cytotoxicity of Palbociclib in U87-MG Glioblastoma Cells Delivered by Dual Peptide Functionalized Nanoparticles
(2023-10-06) Lo, Yu-Chen ; WEN-JEN LIN

Synergistic cytotoxicity of irinotecan combined with polysaccharide-based nanoparticles for colorectal carcinoma
(2023-10) Pai, Fang-Ting ; WEN-JEN LIN

Benefit of a Short Chain Peptide as a Targeting Ligand of Nanocarriers for a Brain-Driven Purpose
(2021-08-12) Lo, Yu-Chen ; WEN-JEN LIN

Peptide-Functionalized Nanoparticles-Encapsulated Cyclin-Dependent Kinases Inhibitor Seliciclib in Transferrin Receptor Overexpressed Cancer Cells
(2021-03-18) He, Guan Zhen ; WEN-JEN LIN

Dual peptide-modified nanoparticles improve combination chemotherapy of etoposide and siPIK3CA against drug-resistant small cell lung carcinoma
(2020) Huang H.-L. ; WEN-JEN LIN

more

Functional Cutaneous Nano Delivery System Combines Tacrolimus in the Treatment of Atopic Dermatitis with Synergistic Potential
(2023-08-01~) WEN-JEN LIN

Development of Nanomedicine to Enhance Transcytosis of Cdk Iv Inhibitors across Blood Brain Barrier and Its Potential for Treatment of Glioma
(2022-08-01~) WEN-JEN LIN

Development of Nanomedicine to Enhance Transcytosis of Cdk Iv Inhibitors across Blood Brain Barrier and Its Potential for Treatment of Glioma
(2021-08-02~) WEN-JEN LIN

Development of Nanomedicine to Enhance Transcytosis of Cdk IV Inhibitors across Blood Brain Barrier and Its Potential for Treatment of Glioma
(2020-08-01~) WEN-JEN LIN

Develop a New Iron-Based Chitosan as an Oral Phosphate Binder: in Vi Tro and in Vi Vo Studies
(2019-08-01~) WEN-JEN LIN

more